Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual Property

Management Anticipates $300,000+ Reduction in Annual Operating Costs

HOUSTON, Dec. 23, 2021 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announced that, as part of its ongoing comprehensive evaluation of its business, it will wind down the business operations of its VectorVision business and, instead, focus on exploiting its valuable intellectual property and technology using a restructured and more cost-efficient approach.

The Company is exploring both domestic and international business opportunities, such as licensing and distribution arrangements, with qualified parties, to assist the Company in the economic exploitation of these intellectual property rights, including the VectorVision patents. As a result of this change to the VectorVision business strategy, management believes that it…

Read more…